#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pustular psoriasis Squamous cell carcinoma of the cervix Stevens-Johnson syndrome Soft tissue necrosis Acute lymphocytic leukaemia Red blood cell abnormality Hydrocephalus Ependymoma Neoplasm malignant Angiosarcoma non-metastatic Hidradenitis Primary biliary cholangitis Haemophagocytic lymphohistiocytosis Methylmalonic acidaemia Piriformis syndrome More trials…

    Learn about Rare Diseases

    Leiomyosarcoma – Treatment Hereditary motor and sensory neuropathy – Basic Information Hereditary ataxia – Diagnostics Rhabdomyosarcoma recurrent – Basic Information Alagille syndrome – Diagnostics Amyotrophic lateral sclerosis – Life with Disease Glycogen storage disease type I Acute respiratory distress syndrome – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Nephroblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzyl Alcohol GVV858 Octocog Alfa Histamine Dihydrochloride Rbd4059 Vericiguat Glucose Monohydrate Fremanezumab Peposertib Elraglusib Co-Trimoxazole Prednisolone Acetate Clofutriben Phenylalanine Abemaciclib STREPTOCOCCUS PYOGENES Glycopyrronium Bromide Crovalimab HUMAN THROMBIN Lamivudine More therapies…

    Learn about Your Condition

    Neutropenia Cholecystitis acute Eclampsia Neurogenic bladder Melanoma recurrent Obsessive-compulsive disorder Lung neoplasm malignant Adenomyosis Oesophageal atresia Herpes simplex Pemphigus Eosinophilic oesophagitis Oral neoplasm Mitral valve prolapse Carcinoid tumour pulmonary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire De La Reunion

Centre Hospitalier Universitaire De La Reunion

Ajwjb Dct Tuqgjtrf Ci 1alkqw Sx Dizxuk 9uoxdi Fdhanv

Want to learn more about this study or check if you can participate? Contact us.

  • Cabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabozantinib
    Denmark Finland France Italy The Netherlands Poland +2

  • Treatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute promyelocytic leukaemia
    Investigated Drugs:
    • Arsenic Trioxide
    • Methylprednisolone Sodium Succinate
    • Gemtuzumab Ozogamicin
    Czechia France Italy The Netherlands Sweden

  • Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Ustekinumab
    • Deucravacitinib
    Belgium Bulgaria Czechia Denmark France Germany +6

  • Study of Regorafenib and Maintenance Chemotherapy for Newly Diagnosed Ewing Sarcoma Patients with Metastatic Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Vinorelbine
    • Cyclophosphamide
    Denmark France The Netherlands Norway Spain

  • Study on the Effectiveness and Safety of Circumcision and Antibiotic Treatment (Cefaclor, Sulfamethoxazole, Trimethoprim) for Boys with Posterior Urethral Valves

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Urethral valves
    Investigated Drugs:
    • Cefaclor
    • Clavulanic Acid
    • Amoxicillin
    France

  • Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lenalidomide
    • Elranatamab
    • Bortezomib
    Belgium France

  • Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

    Recruiting

    3 1 1 1
    France

  • Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Pembrolizumab
    Belgium France

  • Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +4

  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    • Polycythaemia vera
    Investigated Drugs:
    • Apixaban
    • Rivaroxaban
    • Acetylsalicylic Acid
    France
1 2 3 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!